Covid-19 roundup: Temasek leads a $250M raise for BioN­Tech as first Covid-19 mR­NA vac­cine da­ta looms; Chi­na's mil­i­tary OKs first use of coro­n­avirus vac­cine

Sin­ga­pore’s gi­ant fund run by Temasek is putting some fi­nan­cial mus­cle be­hind BioN­Tech $BN­TX as the Pfiz­er part­ner pre­pares to post the first cut of its da­ta on their mR­NA vac­cine to com­bat Covid-19.

Temasek is lead­ing a $250 mil­lion in­jec­tion in­to the Ger­man biotech, one of a small pack of mR­NA play­ers at­tempt­ing to field a vac­cine to fight the glob­al pan­dem­ic that’s been rat­tling the world. Mod­er­na is in front of the mR­NA pack with Phase III plans.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN